Showing results (621-630 of 833) with videos related to

Sort By:
Pageof 84
AIDS (London, England)|September 22, 2007
The ability of four genotypic interpretation systems to predict virological response to ritonavir-boosted protease inhibitorsZoe V Fox, Anna Maria Geretti, Jesper Kjaer, et al.
AIDS (London, England)|January 16, 2008
Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDAWendy P Bannister, Lidia Ruiz, Alessandro Cozzi-Lepri, et al.
Open Forum Infectious Diseases|June 8, 2018
Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell TransplantationI P Lodding, C da Cunha Bang, S S Sørensen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2012
HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunctionJason V Baker, Jacqueline Neuhaus, Daniel Duprez, et al.
Lancet (London, England)|December 16, 1998
Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study GroupA Mocroft, S Vella, T L Benfield, et al.
Eating Behaviors|January 3, 2008
The Night Eating Questionnaire (NEQ): psychometric properties of a measure of severity of the Night Eating SyndromeKelly C Allison, Jennifer D Lundgren, John P O'Reardon, et al.
AIDS (London, England)|January 10, 2015
Thrombocytopenia is associated with an increased risk of cancer during treated HIV diseaseÁlvaro H Borges, Jens D Lundgren, Annalisa Ridolfo, et al.
AIDS (London, England)|August 28, 2007
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-scoreAmanda Mocroft, Bruno Ledergerber, Kai Zilmer, et al.
AIDS (London, England)|April 7, 2007
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimenAlessandro Cozzi-Lepri, Andrew N Phillips, Lidia Ruiz, et al.
The Journal of Infectious Diseases|July 17, 2009
Rate of accumulation of thymidine analogue mutations in patients continuing to receive virologically failing regimens containing zidovudine or stavudine: implications for antiretroviral therapy programs in resource-limited settingsAlessandro Cozzi-Lepri, Andrew N Phillips, Javier Martinez-Picado, et al.
Pageof 84